Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
The Great Workplace Shakeup: Adapting Workers' Comp for the Remote Revolution
The growing trend of remote and hybrid work models has introduced new regulatory challenges to be addressed for the worke
Mitchell
Article
Plugged-In: EV Collision Insights Q1 2024
Workers' Comp
Podcast
Cool Tips for Beating the Heat at Work
Mitchell
News Release
Decrease in Used Electric Vehicle Prices Coincides with an Increase in Total Loss Claims
Mitchell’s latest trends report shows a jump in total loss frequency for both electric and newer internal combustion engine (ICE) automobiles.
Workers' Comp
Article
Ask The Pharmacist: Urine Drug Testing in Workers’ Compensation
Who should receive urine drug testing and how often? Urine drug testing (UDT) plays an important role in wor
Workers' Comp
Article
Consolidated Appropriations Act, 2024: The Impact on Workers' Compensation and Auto Casualty Sectors
On March 9, 2024, President Biden signed the Consolidated A